RIPK1 and Parkinson disease: Notably, Nec-1 treatment significantly ameliorated anxiety-like behavior of PD mice, as indicated by more grids, faster average speed and longer distance in Figure 3E. These results indicate that inhibiting RIPK1 could efficiently ameliorate motor and non-motor dysfunctions in PD mice.